Navigation Links
Data From Global Atrial Fibrillation Registry Show Antithrombotic Agents Not Optimally Used to Prevent Stroke
Date:9/2/2014

t University College London and Director of the TRI. "Previous research has demonstrated that patient outcomes can be improved when anticoagulant therapy is used appropriately. However, observations of everyday clinical practice in GARFIELD-AF suggest that important work remains to be done to ensure the implementation of evidence-based best practice, including the selection of suitable patients for anticoagulation and their optimal management."

Preliminary treatment data for 31,666 GARFIELD-AF patients enrolled in 34 countries during the first three of five planned cohorts were presented in an ESC Congress 2014 satellite symposium.[2] Since the initiation of GARFIELD-AF in 2009, regulatory approval for NOACs including factor Xa inhibitors (rivaroxaban, apixaban) and a direct thrombin inhibitor (dabigatran) has altered prescribing patterns by providing an alternative to vitamin K antagonists (VKAs), the established standard of care. The proportion of AF patients receiving a NOAC has increased from 3.1% during cohort 1 (December 2009-October 2011) to 26.4% during cohort 3 (June 2013-June 2014). However, the proportion of patients receiving any anticoagulant only increased from 60.6% to 67.5% in the same period, as fewer patients received a VKA (57.5% to 41.1%).

The 12,448 prospective patients with at least one year of follow up data after AF diagnosis at the time of analysis were included in the three posters presented at ESC Congress 2014.

Only 25% of patients treated with VKAs achieve adequate anticoagulation control[3] 

  • The ESC guidelines suggest that patients can be considered well managed on VKA therapy if they spend at least 70% of their time in the therapeutic range, i.e. with an international normalized ratio (INR) of 2.0-3.0.[4]
  • The requirement for patients on VKA to undergo routine monitoring and dose adjustment, and the diffic
    '/>"/>

SOURCE GARFIELD-AF
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Avanir Pharmaceuticals to Present at the Morgan Stanley Global Healthcare Conference
2. Abaxis, Inc. to Present at the Morgan Stanley Global Healthcare Conference
3. Hologic to Present at the Morgan Stanley Global Healthcare Conference
4. Mast Therapeutics To Present At The Rodman And Renshaw 16th Annual Global Investment Conference On September 9th
5. Veracyte to Present at the Morgan Stanley Global Healthcare Unplugged Conference 2014
6. CAGR of 10.1% Global Biological Drugs Market - Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 to 2020: Report by MarketResearchReports.Biz
7. Contract Research Organization WCCT Global Celebrates Being Named as One of the Fastest Growing Companies in America
8. Drug Discovery Technologies - A Global Market Overview
9. Rigid Transparent Plastics: Global Markets Outside North America
10. X-Ray Crystallography Scanner Industry For Global and Chinese Market Forecast to 2019
11. Global Peptide Cancer Therapeutics Market & Pipeline Insight 2014
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... 30, 2014  Hologic, Inc. (NASDAQ: HOLX ... President and Chief Executive Officer, will preside over the ... the first day of Breast Cancer Awareness Month. In ... focused on the important benefits of Hologic,s 3D Mammography ... as clinically superior to traditional mammography. ...
(Date:9/30/2014)... 30, 2014 This study provides an ... informatics solutions including nuclear imaging informatics, PET imaging ... study assesses the size of the market based ... and projects future growth based on the current ... taking place in the broader markets for imaging ...
(Date:9/30/2014)... , Sept. 30, 2014 Aileron ... Summary Global Markets Direct,s, ,Aileron Therapeutics, ... an overview of the Aileron Therapeutics, Inc.,s pharmaceutical ... comprehensive information on the current therapeutic developmental pipeline ... at various stages, therapeutics assessment by drug target, ...
Breaking Medicine Technology:Hologic to Kick Off National Breast Cancer Awareness Month at the October 1 NASDAQ Stock Market Opening Bell Ceremony 2Hologic to Kick Off National Breast Cancer Awareness Month at the October 1 NASDAQ Stock Market Opening Bell Ceremony 3Analysis of the US Molecular Imaging Informatics Market 2Analysis of the US Molecular Imaging Informatics Market 3Aileron Therapeutics, Inc. - Product Pipeline Review - 2014 2Aileron Therapeutics, Inc. - Product Pipeline Review - 2014 3
... OrthoWorx, the newly formed industry, community and education initiative to ... is working to connect the orthopedics capital of the world ... , In a September report, Warsaw, ... overview, analysis and blueprint for future industry and community growth, ...
... , , KNOXVILLE, Tenn., Dec. 15 Medical researchers ... their revolutionary new technology for a simple blood test to ... of its pre-clinical trials for the ColoMarker(TM) assay, EDP has ... of its use. Via an inexpensive blood test, ColoMarker(TM) ...
Cached Medicine Technology:OrthoWorx Urges Warsaw's Inclusion on High-Speed Rail Corridor Connecting Chicago and Cleveland 2OrthoWorx Urges Warsaw's Inclusion on High-Speed Rail Corridor Connecting Chicago and Cleveland 3Researchers Announce Medical Breakthrough with Simple, Inexpensive Blood Test for Colon Cancer 2
(Date:10/1/2014)... Conn. (PRWEB) October 01, 2014 ... company, including a redefined mission and visual identity ... power of partnering with them to create greater ... agile brand that focuses on empowering customers to ... communications. , The crown jewel of the rebrand ...
(Date:10/1/2014)... N.C. A new genetic finding from Duke Medicine ... anxiety and depression might also be hard-wired to gain ... and heart disease. , An estimated 13 percent of ... genetic susceptibility, and knowing this could help them reduce ... diet, exercise and stress management. , "Genetic susceptibility, psychosocial ...
(Date:10/1/2014)... (PRWEB) October 01, 2014 Between 23 ... in the U.S., according to figures from the National ... Diseases Association (AARDA), and many of them have something ... of having undiagnosed celiac disease. Gluten Free Therapeutics, ... awareness of undiagnosed celiac disease by publishing a series ...
(Date:10/1/2014)... City, NJ (PRWEB) October 01, 2014 Diet ... with their intentions to lose weight and their dieting attempts ... unhealthy, fatty foods. Including hormone diet treatments into ... only allows patients to see fast and effective weight loss ... and begin forming healthy habits to maintain their weight for ...
(Date:10/1/2014)... (PRWEB) October 01, 2014 Anti Aging ... and skin rejuvenating destination of choice, is announcing a ... October through to December. , “We’re doing this because ... possible to our top skin clinic in Toronto,” says ... do so much at Anti Aging Clinic, including laser ...
Breaking Medicine News(10 mins):Health News:Farmington Company Launches Rebrand and New Positioning 2Health News:Gene interacts with stress and leads to heart disease in some people 2Health News:Informative New Blog Series Underscores Link Between Celiac Disease and Other Autoimmune Disorders 2Health News:Informative New Blog Series Underscores Link Between Celiac Disease and Other Autoimmune Disorders 3Health News:Diet Doc Announces Their New Version of the Hormone Diet Plan to Target, Attack and Burn Fat Without Dangerous Side Effects 2Health News:Diet Doc Announces Their New Version of the Hormone Diet Plan to Target, Attack and Burn Fat Without Dangerous Side Effects 3Health News:Diet Doc Announces Their New Version of the Hormone Diet Plan to Target, Attack and Burn Fat Without Dangerous Side Effects 4Health News:Anti Aging Clinic, the GTA’s Premier Provider of Anti Aging Treatments, Announces Deal on Units of Botox 2
... Study has Important Implications for Genetic Testing and Individualized Medicine ... long QT syndrome (LQTS) study published in ... understanding genetic testing,s role in diagnosing disease, according to the ... A pediatric cardiologist at Mayo Clinic, Dr. Ackerman directs Mayo,s ...
... , DALLAS, Nov. 5 Kimberly-Clark Corporation (NYSE: ... period under the Hart-Scott-Rodino Antitrust Improvements Act with respect ... (Nasdaq: IFLO). , Kimberly-Clark initiated a cash tender offer ... of I-Flow common stock. The tender offer will ...
... Even a slight elevation was linked to coronary artery calcification ... blood levels of phosphorus are associated with a higher risk ... link between phosphorus levels and coronary artery calcification (CAC) in ... long-term investigation of heart disease risk factors. CAC is an ...
... Lumenis® ... ophthalmic, surgical and aesthetic applications, announced today the initiation of a clinical study into ... will take place at the Tel Aviv Medical Center in Israel, under the leadership ... ...
... Pharmaceuticals, Inc. (Nasdaq: CADX ), a biopharmaceutical ... product candidates principally for use in the hospital ... and nine months ended September 30, 2009. , ... the FDA for Cadence,s New Drug Application (NDA) ...
... could aid understanding of human diseases, scientists say , ... the domestic horse has been sequenced, an accomplishment that ... studies of human health, according to an international team ... makes it easier to understand all genomes, including our ...
Cached Medicine News:Health News:Research Findings Key for Understanding, Interpreting Genetic Testing for Long QT Syndrome 2Health News:Research Findings Key for Understanding, Interpreting Genetic Testing for Long QT Syndrome 3Health News:Kimberly-Clark Corporation Announces Regulatory Clearance for Its Planned Acquisition of I-Flow Corporation 2Health News:Kimberly-Clark Corporation Announces Regulatory Clearance for Its Planned Acquisition of I-Flow Corporation 3Health News:Kimberly-Clark Corporation Announces Regulatory Clearance for Its Planned Acquisition of I-Flow Corporation 4Health News:Phosphorus Levels May Predict Heart Disease 2Health News:Lumenis Announces the Initiation of a Clinical Study into the Efficacy of Selective Retina Therapy (SRT) in Diabetic Macular Edema (DME) 2Health News:Lumenis Announces the Initiation of a Clinical Study into the Efficacy of Selective Retina Therapy (SRT) in Diabetic Macular Edema (DME) 3Health News:Lumenis Announces the Initiation of a Clinical Study into the Efficacy of Selective Retina Therapy (SRT) in Diabetic Macular Edema (DME) 4Health News:Lumenis Announces the Initiation of a Clinical Study into the Efficacy of Selective Retina Therapy (SRT) in Diabetic Macular Edema (DME) 5Health News:Lumenis Announces the Initiation of a Clinical Study into the Efficacy of Selective Retina Therapy (SRT) in Diabetic Macular Edema (DME) 6Health News:Cadence Pharmaceuticals Reports Third Quarter 2009 Financial Results 2Health News:Cadence Pharmaceuticals Reports Third Quarter 2009 Financial Results 3Health News:Cadence Pharmaceuticals Reports Third Quarter 2009 Financial Results 4Health News:Cadence Pharmaceuticals Reports Third Quarter 2009 Financial Results 5Health News:Cadence Pharmaceuticals Reports Third Quarter 2009 Financial Results 6Health News:Cadence Pharmaceuticals Reports Third Quarter 2009 Financial Results 7Health News:Complete Horse Genome Sequence Revealed 2
Anatomically designed 3 cervical foam collar...
One-piece rigid cervical collar is designed to fit securely around the neck and mandible to provide immobilization and support of the cervical region...
This model utilizes the Malibu Soft Cervical Collar with a Thoracic Extension....
Model C-10 is a four post cervical orthosis which controls flexion, extension, lateral flexion, rotation, and axial motion. Each post may be individually adjusted in height....
Medicine Products: